Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patients

Haematologica. 2023 Oct 1;108(10):2799-2802. doi: 10.3324/haematol.2022.282510.

Authors

Nico Gagelmann¹, Francis A Ayuk¹, Evgeny Klyuchnikov¹, Christine Wolschke¹, Susanna Carolina Berger¹, Nicolaus Kröger²

Affiliations

¹ Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg.
² Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg. nkroeger@uke.uni-hamburg.de.

No abstract available

Publication types

Meta-Analysis

MeSH terms

B-Cell Maturation Antigen
Cell- and Tissue-Based Therapy
Humans
Immunotherapy, Adoptive / adverse effects
Multiple Myeloma* / therapy
Receptors, Antigen, T-Cell / genetics
Receptors, Chimeric Antigen* / genetics
T-Lymphocytes

Substances

Receptors, Chimeric Antigen
B-Cell Maturation Antigen
Receptors, Antigen, T-Cell